Medartis Holding AG Capital Reinvestment Ratio

Latest as of June 2026: 2.94x

Medartis Holding AG capital reinvestment ratio. Medartis Holding AG (MED) has a Capital Reinvestment Ratio of 2.94x as of June 2026, meaning it reinvests 3% of its operating cash flow (CHF5.30 Million) in capital expenditures (CHF15.59 Million). See MED free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

2.94x
Capex / Operating Cash Flow

Operating Cash Flow

CHF5.30 Million
CHF

Capital Expenditures

CHF15.59 Million
CHF

Data as of

Jun 2026
Most recent filing

Capital Reinvestment Ratio of Medartis Holding AG (2015–2025)

Capital reinvestment ratio of Medartis Holding AG from 2015 to 2025. This chart tracks Medartis Holding AG's Capital Reinvestment Ratio across 10 annual periods. See MED financial flexibility score to measure the company's free cash flow as a share of total liabilities.

Medartis Holding AG Capital Reinvestment Ratio by Year (2015–2025)

Medartis Holding AG capital reinvestment ratio by year from 2015 to 2025. For the full cash flow conversion analysis, see MED cash flow conversion.

Year Reinvestment Ratio Operating CF (CHF) Capital Expenditures YoY Change
2025 0.73x CHF34.82 Million CHF25.48 Million ▲ +227.2%
2024 0.22x CHF32.07 Million CHF7.17 Million ▼ -70.1%
2023 0.75x CHF19.98 Million CHF14.93 Million ▲ +50.8%
2021 0.50x CHF20.95 Million CHF10.39 Million ▼ -52.2%
2020 1.04x CHF12.61 Million CHF13.07 Million ▼ -56.7%
2019 2.39x CHF8.11 Million CHF19.42 Million ▲ +6.6%
2018 2.25x CHF6.45 Million CHF14.48 Million ▲ +181.4%
2017 0.80x CHF11.01 Million CHF8.79 Million ▲ +11.5%
2016 0.72x CHF11.91 Million CHF8.53 Million ▼ -23.1%
2015 0.93x CHF11.88 Million CHF11.06 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow